Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8081
Reference
MSAN(2024)07
Name
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials - update
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
The supply position of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebules has improved.
Salbutamol 2.5mg/2.5ml nebules will be in limited supply from mid-April until late June 2024.
Salbutamol 5mg/2.5ml nebules will remain available, however, cannot support an increase in demand.
Unlicensed supplies of salbutamol 2.5mg/2.5ml nebules can be sourced (see supporting information), lead times vary.
Alternative beta2-agonists for nebulisation and intravenous administration remain available, however, they cannot support an increase in demand.
Access to licensed salbutamol 2.5mg/2.5ml nebules will be actively monitored and prioritised for primary care and ambulance services who are less able to use unlicensed supplies.
Please note that this MSAN supersedes the National Patient Safety Alert issued on 26 February 2024.
Contact Name
Contact Email
Contact Address
Created
2024-03-08 08:57:00
Click to go back to homepage